These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25232417)

  • 1. Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients.
    Hao M; Pan N; Zhang Q; Wang X
    Int J Clin Exp Med; 2014; 7(8):2253-7. PubMed ID: 25232417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.
    Li DW; Gu Z; Wang C; Ma J; Tang BS; Chen SD; Chan P
    J Neural Transm (Vienna); 2015 May; 122(5):661-7. PubMed ID: 25062988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease.
    Gaig C; Vilas D; Infante J; Sierra M; García-Gorostiaga I; Buongiorno M; Ezquerra M; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    PLoS One; 2014; 9(10):e108982. PubMed ID: 25330404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.
    Sun Q; Wang T; Jiang TF; Huang P; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Aging Dis; 2016 May; 7(3):230-6. PubMed ID: 27330837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.
    Brockmann K; Gröger A; Di Santo A; Liepelt I; Schulte C; Klose U; Maetzler W; Hauser AK; Hilker R; Gomez-Mancilla B; Berg D; Gasser T
    Mov Disord; 2011 Nov; 26(13):2335-42. PubMed ID: 21989859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-Year Longitudinal Study of Motor and Non-motor Symptoms in
    Deng X; Xiao B; Li HH; Ng E; Lo YL; Tan EK; Prakash KM
    Front Neurol; 2019; 10():1379. PubMed ID: 32010044
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
    Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
    Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.
    Alcalay RN; Mirelman A; Saunders-Pullman R; Tang MX; Mejia Santana H; Raymond D; Roos E; Orbe-Reilly M; Gurevich T; Bar Shira A; Gana Weisz M; Yasinovsky K; Zalis M; Thaler A; Deik A; Barrett MJ; Cabassa J; Groves M; Hunt AL; Lubarr N; San Luciano M; Miravite J; Palmese C; Sachdev R; Sarva H; Severt L; Shanker V; Swan MC; Soto-Valencia J; Johannes B; Ortega R; Fahn S; Cote L; Waters C; Mazzoni P; Ford B; Louis E; Levy O; Rosado L; Ruiz D; Dorovski T; Pauciulo M; Nichols W; Orr-Urtreger A; Ozelius L; Clark L; Giladi N; Bressman S; Marder KS
    Mov Disord; 2013 Dec; 28(14):1966-71. PubMed ID: 24243757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).
    Pont-Sunyer C; Hotter A; Gaig C; Seppi K; Compta Y; Katzenschlager R; Mas N; Hofeneder D; Brücke T; Bayés A; Wenzel K; Infante J; Zach H; Pirker W; Posada IJ; Álvarez R; Ispierto L; De Fàbregues O; Callén A; Palasí A; Aguilar M; Martí MJ; Valldeoriola F; Salamero M; Poewe W; Tolosa E
    Mov Disord; 2015 Feb; 30(2):229-37. PubMed ID: 25449044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.
    Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L
    Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.
    Rukmini Mridula K; Borgohain R; Jabeen SA; Padmaja G; Bandaru VS; Ankathi P; Kanikannan MA; Ali Khan MS
    Iran J Neurol; 2015 Apr; 14(2):86-93. PubMed ID: 26056553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.
    Spica V; Pekmezović T; Svetel M; Kostić VS
    J Neurol; 2013 Jan; 260(1):131-7. PubMed ID: 22820720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-motor Symptoms in Patients with Parkinson's Disease: A Cross-sectional Survey.
    Tanveer K; Attique I; Sadiq W; Ahmad A
    Cureus; 2018 Oct; 10(10):e3412. PubMed ID: 30538900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.
    Mestre TA; Pont-Sunyer C; Kausar F; Visanji NP; Ghate T; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kasten M; Wadia PM; Zadikoff C; Kumar P; de Bie RM; Thomsen T; Lang AE; Schüle B; Klein C; Tolosa E; Marras C
    Mov Disord; 2018 Jul; 33(6):960-965. PubMed ID: 29665080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features of LRRK2 Carriers with Parkinson's Disease.
    Kestenbaum M; Alcalay RN
    Adv Neurobiol; 2017; 14():31-48. PubMed ID: 28353277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?
    Loeffler DA; Aasly JO; LeWitt PA; Coffey MP
    J Parkinsons Dis; 2019; 9(3):467-488. PubMed ID: 31322581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease.
    Sánchez-Martínez CM; Choreño-Parra JA; Placencia-Álvarez N; Nuñez-Orozco L; Guadarrama-Ortiz P
    Front Neurol; 2019; 10():1197. PubMed ID: 31798522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of LRRK2 in Parkinson's disease in Han Chinese population.
    Zhang JR; Jin H; Li K; Mao CJ; Yang YP; Wang F; Gu CC; Zhang HJ; Chen J; Liu CF
    Neurobiol Aging; 2018 Dec; 72():187.e5-187.e10. PubMed ID: 30049590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.